Richard W. Paul & Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.9K | Buy |
160
+46
| +40% | +$1.12K | ﹤0.01% | 273 |
|
|
2025
Q1 | $2.37K | Sell |
114
-26
| -19% | -$540 | ﹤0.01% | 282 |
|
|
2024
Q4 | $3.3K | Sell |
140
-8
| -5% | -$188 | ﹤0.01% | 379 |
|
|
2024
Q3 | $3.79K | Sell |
148
-607
| -80% | -$15.5K | ﹤0.01% | 367 |
|
|
2024
Q2 | $17.7K | Sell |
755
-43
| -5% | -$1.01K | 0.01% | 261 |
|
|
2024
Q1 | $23K | Sell |
798
-100
| -11% | -$2.88K | 0.01% | 254 |
|
|
2023
Q4 | $29.5K | Sell |
898
-29
| -3% | -$952 | 0.01% | 231 |
|
|
2023
Q3 | $25.8K | Sell |
927
-77
| -8% | -$2.15K | 0.01% | 229 |
|
|
2023
Q2 | $34.2K | Buy |
1,004
+192
| +24% | +$6.55K | 0.01% | 233 |
|
|
2023
Q1 | $24.4K | Sell |
812
-3
| -0.4% | -$90 | 0.01% | 253 |
|
|
2022
Q4 | $23K | Buy |
+815
| New | +$23K | 0.01% | 256 |
|